XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Note 15 - Stock-based Compensation and Other Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2023
Notes Tables  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Three Months Ended March 31,

 
  

2023

  

2022

 
  

(in thousands)

 

Stock-based compensation - equity awards

 $675  $404 

Stock-based compensation - liability awards

  (26)  1,018 

Total stock-based compensation

 $649  $1,422 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Three Months Ended March 31,

 
  

2022

 

Weighted average exercise price - ($/share)

 $6.41 

Expected life in years

  6.0 

Average expected volatility

  72

%

Risk-free interest rate

  1.98

%

Expected dividend yield

  2.30

%

Weighted average grant date fair value - ($/share)

 $2.84 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Number of Shares Underlying Options

  

Weighted Average Exercise Price Per Share

  

Weighted Average Remaining Contractual Term

  

Aggregate Intrinsic Value

 
  

(in thousands)

      

(in years)

  

(in thousands)

 

Outstanding at January 1, 2023

  444  $3.98         

Granted

              

Exercised

  (74)  (1.68)        

Unvested shares forfeited

              

Vested shares expired

              

Outstanding at March 31, 2023

  370  $4.40   8.30  $414 

Exercisable at March 31, 2023

  166  $3.91   8.15  $224 
  

Number of Shares Underlying Options

  

Weighted Average Exercise Price Per Share

  

Weighted Average Remaining Contractual Term

  

Aggregate Intrinsic Value

 
  

(in thousands)

      

(in years)

  

(in thousands)

 

Outstanding at January 1, 2023

  387  $1.86         

Granted

              

Exercised

  (99)  (1.50)        

Unvested shares forfeited

              

Vested shares expired

              

Outstanding at March 31, 2023

  288  $1.98   0.81  $732 

Exercisable at March 31, 2023

  288  $1.98   0.81  $732 
Nonvested Restricted Stock Shares Activity [Table Text Block]
  

Restricted Stock

  

Weighted Average Grant Date Fair Value

 
  

(in thousands)

     

Non-vested shares outstanding at January 1, 2023

  665  $4.59 

Awards granted

      

Awards vested

  (205)  4.82 

Awards forfeited

      

Non-vested shares outstanding at March 31, 2023

  460  $4.49 
  

Restricted Stock

  

Weighted Average Conversion Date Fair Value

 
  

(in thousands)

     

Non-vested shares outstanding at January 1, 2023

  383  $4.27 

Awards granted

      

Awards vested

  (121)  4.27 

Awards forfeited

  (23)  4.27 

Non-vested shares outstanding at March 31, 2023

  239  $

4.27

 

Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
  

Restricted Stock

  

Weighted Average Conversion Date Fair Value

 
  

(in thousands)

     

Non-vested shares outstanding at January 1, 2023

  690  $4.27 

Awards granted

      

Awards vested

  (134)  4.27 

Awards forfeited

  (36)  4.27 

Non-vested shares outstanding at March 31, 2023

  520  $4.27 
Share-Based Payment Arrangement, Stock Appreciation Right, Activity [Table Text Block]
  

Number of Shares Underlying SARs

  

Weighted Average Exercise Price Per Share

  

Weighted Average Remaining Contractual Term

  

Aggregate Intrinsic Value

 
  

(in thousands)

      

(in years)

  

(in thousands)

 

Outstanding at January 1, 2023

  202  $1.87         

Granted

              

Exercised

  (63)  0.86         

Unvested SARs forfeited

              

Vested SARs expired

              

Outstanding at March 31, 2023

  139  $2.33   0.92  $304 

Exercisable at March 31, 2023

  139  $2.33   0.92  $304